{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:47:31Z","timestamp":1790423251202,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["GR1617\/14-1\/iPAD"],"award-info":[{"award-number":["GR1617\/14-1\/iPAD"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["390874280"],"award-info":[{"award-number":["390874280"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["390939984"],"award-info":[{"award-number":["390939984"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["403222702 \u2013 SFB 1381"],"award-info":[{"award-number":["403222702 \u2013 SFB 1381"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC-2189"],"award-info":[{"award-number":["EXC-2189"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RESIST \u2013 EXC 2155"],"award-info":[{"award-number":["RESIST \u2013 EXC 2155"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1160\/2_B5"],"award-info":[{"award-number":["SFB1160\/2_B5"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GM1910A"],"award-info":[{"award-number":["01GM1910A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003390","name":"Fritz Thyssen Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014746","name":"Cambridge Conservation Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014746","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.bj.2021.04.005","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T18:54:50Z","timestamp":1618944890000},"page":"400-411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes"],"prefix":"10.1016","volume":"44","author":[{"given":"Laura","family":"G\u00e1mez-D\u00edaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodo","family":"Grimbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bj.2021.04.005_bib1","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood.V89.3.902","article-title":"Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis","volume":"89","author":"Bettinardi","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bj.2021.04.005_bib2","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7539157","article-title":"Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity","volume":"268","author":"Rieux-Laucat","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.bj.2021.04.005_bib3","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","article-title":"Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome","volume":"81","author":"Fisher","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bj.2021.04.005_bib4","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.bj.2021.04.005_bib5","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ajhg.2012.04.015","article-title":"Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity","volume":"90","author":"Lopez-Herrera","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bj.2021.04.005_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaci.2015.09.025","article-title":"The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency","volume":"137","author":"G\u00e1mez-D\u00edaz","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib7","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib8","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jaci.2018.10.026","article-title":"Tregopathies: monogenic diseases resulting in regulatory T-cell deficiency","volume":"142","author":"Cepika","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib9","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nrg1944","article-title":"Genetics of autoimmune diseases--disorders of immune homeostasis","volume":"7","author":"Gregersen","year":"2006","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.bj.2021.04.005_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.2011.01019.x","article-title":"Mechanisms of tolerance","volume":"241","author":"Bluestone","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bj.2021.04.005_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.autrev.2010.08.019","article-title":"Recent insights into the role and molecular mechanisms of the autoimmune regulator (AIRE) gene in autoimmunity","volume":"10","author":"Fierabracci","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.bj.2021.04.005_bib12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng1297-399","article-title":"An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains","volume":"17","author":"Aaltonen","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.bj.2021.04.005_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.immuni.2005.07.005","article-title":"The cellular mechanism of Aire control of T cell tolerance","volume":"23","author":"Anderson","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.bj.2021.04.005_bib14","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.1056600","article-title":"Contribution of receptor editing to the antibody repertoire","volume":"291","author":"Casellas","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bj.2021.04.005_bib15","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1182\/blood-2010-11-321752","article-title":"Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL","volume":"117","author":"Sinha","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bj.2021.04.005_bib16","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.12688\/f1000research.11545.1","article-title":"Autoimmune lymphoproliferative syndrome: more than a FAScinating disease","volume":"6","author":"Bride","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.bj.2021.04.005_bib17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1084\/jem.183.3.721","article-title":"Fas and the art of lymphocyte maintenance","volume":"183","author":"Lenardo","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.bj.2021.04.005_bib18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0092-8674(00)81874-7","article-title":"Apoptosis by death factor","volume":"88","author":"Nagata","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bj.2021.04.005_bib19","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/356314a0","article-title":"Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis","volume":"356","author":"Watanabe-Fukunaga","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.bj.2021.04.005_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/icb.2014.99","article-title":"Double negative (DN) alphabeta T cells: misperception and overdue recognition","volume":"93","author":"Martina","year":"2015","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.bj.2021.04.005_bib21","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2013-10-535393","article-title":"Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations","volume":"123","author":"Price","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bj.2021.04.005_bib22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1203\/00006450-200003000-00009","article-title":"Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?","volume":"47","author":"van der Burg","year":"2000","journal-title":"Pediatr Res"},{"key":"10.1016\/j.bj.2021.04.005_bib23","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1126\/science.1260791","article-title":"Immunology. Autoimmunity by haploinsufficiency","volume":"345","author":"Rieux-Laucat","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.bj.2021.04.005_bib24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1182\/blood-2015-11-685024","article-title":"Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome","volume":"128","author":"V\u00f6lkl","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bj.2021.04.005_bib25","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jaip.2019.02.018","article-title":"Clinical aspects of STAT3 gain-of-function germline mutations: a systematic review","volume":"7","author":"Fabre","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.bj.2021.04.005_bib26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","article-title":"Clinical spectrum and features of activated phosphoinositide 3-kinase delta syndrome: a large patient cohort study","volume":"139","author":"Coulter","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib27","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.jaci.2018.01.039","article-title":"Loss-of-function nuclear factor kappaB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans","volume":"142","author":"Tuijnenburg","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fimmu.2019.00297","article-title":"Clinical and immunological phenotype of patients with primary immunodeficiency due to damaging mutations in NFKB2","volume":"10","author":"Klemann","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1073\/pnas.96.1.185","article-title":"A two-step, two-signal model for the primary activation of precursor helper T cells","volume":"96","author":"Bretscher","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bj.2021.04.005_bib30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Canc"},{"key":"10.1016\/j.bj.2021.04.005_bib31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.bj.2021.04.005_bib32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.182.2.459","article-title":"CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation","volume":"182","author":"Krummel","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.bj.2021.04.005_bib33","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","article-title":"Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death","volume":"11","author":"Ishida","year":"1992","journal-title":"EMBO J"},{"key":"10.1016\/j.bj.2021.04.005_bib34","doi-asserted-by":"crossref","first-page":"8099","DOI":"10.1073\/pnas.94.15.8099","article-title":"Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer","volume":"94","author":"Kwon","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bj.2021.04.005_bib35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/intimm\/dxh194","article-title":"PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells","volume":"17","author":"Iwai","year":"2005","journal-title":"Int Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib36","doi-asserted-by":"crossref","first-page":"102526","DOI":"10.1016\/j.autrev.2020.102526","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: a systematic review","volume":"19","author":"Park","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.bj.2021.04.005_bib37","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bj.2021.04.005_bib38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","article-title":"An essential role for Scurfin in CD4+CD25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib39","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib40","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nri3108","article-title":"The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses","volume":"11","author":"Walker","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib41","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1126\/science.aac7888","article-title":"IMMUNOLOGY. Moving CTLA-4 from the trash to recycling","volume":"349","author":"Sansom","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bj.2021.04.005_bib42","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1074-7613(00)80480-X","article-title":"Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement","volume":"4","author":"Linsley","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.bj.2021.04.005_bib43","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bj.2021.04.005_bib44","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s10875-019-00677-6","article-title":"A spectrum of clinical findings from ALPS to CVID: several novel LRBA defects","volume":"39","author":"Cagdas","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib45","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.bj.2021.04.005_bib46","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.3389\/fimmu.2018.02012","article-title":"Increased risk for malignancies in 131 affected CTLA4 mutation carriers","volume":"9","author":"Egg","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib47","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.chom.2015.04.010","article-title":"Microbiota and autoimmunity: exploring new avenues","volume":"17","author":"Yurkovetskiy","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bj.2021.04.005_bib48","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/1074-7613(95)90125-6","article-title":"Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4","volume":"3","author":"Tivol","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.bj.2021.04.005_bib49","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.3389\/fimmu.2017.01824","article-title":"An activating janus kinase-3 mutation is associated with cytotoxic T lymphocyte antigen-4-dependent immune dysregulation syndrome","volume":"8","author":"Sic","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib50","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2017.07.014","article-title":"Lessons from CTLA-4 deficiency and checkpoint inhibition","volume":"49","author":"Lo","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib51","doi-asserted-by":"crossref","first-page":"999","DOI":"10.4049\/jimmunol.1400504","article-title":"Effector T cells boost regulatory T cell expansion by IL-2, TNF, OX40, and plasmacytoid dendritic cells depending on the immune context","volume":"194","author":"Baeyens","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib52","doi-asserted-by":"crossref","first-page":"13451","DOI":"10.1073\/pnas.0901984106","article-title":"Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells","volume":"106","author":"Rakhmanov","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bj.2021.04.005_bib53","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.immuni.2014.12.005","article-title":"The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells","volume":"41","author":"Sage","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.bj.2021.04.005_bib54","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1172\/JCI85647","article-title":"Deficiency of base excision repair enzyme NEIL3 drives increased predisposition to autoimmunity","volume":"126","author":"Massaad","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bj.2021.04.005_bib55","doi-asserted-by":"crossref","first-page":"8767","DOI":"10.1002\/jcp.26772","article-title":"The imbalance of circulating T helper subsets and regulatory T cells in patients with LRBA deficiency: correlation with disease severity","volume":"233","author":"Azizi","year":"2018","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bj.2021.04.005_bib56","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.immuni.2014.12.006","article-title":"Regulatory T cells control antigen-specific expansion of Tfh cell number and humoral immune responses via the coreceptor CTLA-4","volume":"41","author":"Wing","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.bj.2021.04.005_bib57","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/pai.12735","article-title":"Clinical, immunologic, molecular analyses and outcomes of iranian patients with LRBA deficiency: a longitudinal study","volume":"28","author":"Azizi","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib58","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.jaip.2019.04.011","article-title":"Clinical, immunologic, and molecular spectrum of patients with LPS-responsive beige-like anchor protein deficiency: a systematic review","volume":"7","author":"Habibi","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.bj.2021.04.005_bib59","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.jaci.2019.12.896","article-title":"Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score","volume":"145","author":"Tesch","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib60","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.4049\/jimmunol.166.7.4586","article-title":"Identification of a novel lipopolysaccharide-inducible gene with key features of both A kinase anchor proteins and chs1\/beige proteins","volume":"166","author":"Wang","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib61","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/tra.12069","article-title":"The BEACH is hot: a LYST of emerging roles for BEACH-domain containing proteins in human disease","volume":"14","author":"Cullinane","year":"2013","journal-title":"Traffic"},{"key":"10.1016\/j.bj.2021.04.005_bib62","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/mgme.1999.2927","article-title":"Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome","volume":"68","author":"Introne","year":"1999","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bj.2021.04.005_bib63","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/ni.2524","article-title":"Plasma cells require autophagy for sustainable immunoglobulin production","volume":"14","author":"Pengo","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib64","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/icb.2017.52","article-title":"Immunological phenotype of the murine Lrba knockout","volume":"95","author":"G\u00e1mez-D\u00edaz","year":"2017","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.bj.2021.04.005_bib65","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/icb.2017.50","article-title":"Murine LRBA deficiency causes CTLA-4 deficiency in Tregs without progression to immune dysregulation","volume":"95","author":"Burnett","year":"2017","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.bj.2021.04.005_bib66","doi-asserted-by":"crossref","first-page":"11380","DOI":"10.1073\/pnas.1901407116","article-title":"Enhanced susceptibility to chemically induced colitis caused by excessive endosomal TLR signaling in LRBA-deficient mice","volume":"116","author":"Wang","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bj.2021.04.005_bib67","doi-asserted-by":"crossref","first-page":"36568","DOI":"10.1038\/srep36568","article-title":"LRBA is essential for allogeneic responses in bone marrow transplantation","volume":"6","author":"Park","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.bj.2021.04.005_bib68","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1038\/sj.onc.1207567","article-title":"Deregulated expression of LRBA facilitates cancer cell growth","volume":"23","author":"Wang","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bj.2021.04.005_bib69","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1532\/IJH97.04053","article-title":"Gene expression profiling of human erythroid progenitors by micro-serial analysis of gene expression","volume":"80","author":"Fujishima","year":"2004","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bj.2021.04.005_bib70","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1182\/blood-2010-04-280347","article-title":"Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop","volume":"116","author":"Oliveira","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bj.2021.04.005_bib71","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3389\/fimmu.2018.00720","article-title":"Rapid flow cytometry-based test for the diagnosis of lipopolysaccharide responsive beige-like anchor (LRBA) deficiency","volume":"9","author":"G\u00e1mez-D\u00edaz","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib72","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s10875-020-00799-2","article-title":"Clinical phenotypes and immunological characteristics of 18 Egyptian LRBA deficiency patients","volume":"40","author":"Meshaal","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib73","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood-2016-10-745174","article-title":"Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations","volume":"129","author":"Hou","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bj.2021.04.005_bib74","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.4049\/jimmunol.1401876","article-title":"A transendocytosis model of CTLA-4 function predicts its suppressive behavior on regulatory T cells","volume":"194","author":"Hou","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib75","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1038\/s41467-019-10812-x","article-title":"Human DEF6 deficiency underlies an immunodeficiency syndrome with systemic autoimmunity and aberrant CTLA-4 homeostasis","volume":"10","author":"Serwas","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.bj.2021.04.005_bib76","series-title":"GeneReviews((R)). Seattle (WA): University of Washington, Seattle","article-title":"Autoimmune lymphoproliferative syndrome","author":"Bleesing","year":"1993"},{"key":"10.1016\/j.bj.2021.04.005_bib77","doi-asserted-by":"crossref","first-page":"235","DOI":"10.23822\/EurAnnACI.1764-1489.22","article-title":"New therapeutic approach by sirolimus for enteropathy treatment in patients with LRBA deficiency","volume":"49","author":"Azizi","year":"2017","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib78","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/MIB.0000000000000266","article-title":"Atypical manifestation of LRBA deficiency with predominant IBD-like phenotype","volume":"21","author":"Serwas","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bj.2021.04.005_bib79","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jaci.2016.01.045","article-title":"Hematopoietic stem cell transplantation for CTLA4 deficiency","volume":"138","author":"Slatter","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.bj.2021.04.005_bib80","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00393-009-0533-4","article-title":"[Selective co-stimulation blockade. CTLA4-Ig (Abatacept)]","volume":"69","author":"Alten","year":"2010","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.bj.2021.04.005_bib81","article-title":"Abatacept is effective in Chinese patients with LRBA and CTLA4 deficiency","author":"Lu","year":"2020","journal-title":"Gene Dis. Forthcoming"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S231941702100038X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S231941702100038X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:09:37Z","timestamp":1762420177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S231941702100038X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":81,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S231941702100038X"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2021.04.005","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739980924.793589833","asserted-by":"object"}]},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2021.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Chang Gung University. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}